[1]
Podder, S., Masudur Rahman, M., Hossain, M.I., Datta, R., Alam, J. and Golam Kibria, M. 2024. Efficacy of rifaximin among non-constipated irritable bowel syndrome patients with or without small intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. International Journal of Research in Medical Sciences. 12, 4 (Mar. 2024), 1056–1064. DOI:https://doi.org/10.18203/2320-6012.ijrms20240825.